Skip to main content
. 2020 May 1;2020(5):CD011368. doi: 10.1002/14651858.CD011368.pub2

6.8. Analysis.

Comparison 6: Topical salicylic acid versus no treatment, Outcome 8: Quality of life (QoL) ‐ AQOL (score, post‐intervention)

Quality of life (QoL) ‐ AQOL (score, post‐intervention)
Study Time points Salicylic acid (median, 95%CI) No treatment (median, 95%CI) P value
Akarsu 2012 Long term: 12 weeks after start of treatment 0.5 (0.6‐2.1) 1 (1.5‐4.3) Quote: "there were no significant differences in AQOL between treatment groups at baseline and at the end of the study".